Abstract:OBJECTIVE:To evaluate the bioequivalence of two kinds of isosorbide mononitrate sustained tablets in Chinese healthy volunteers.METHODS:According to two formulas double period crossover protocol,a total of 18 healthy volunteers were orally administered with test prepartion(T)or reference preparation(R)(40mg),1w later,they were administered with R or T by a crossover way.For multidoese trial,the patients received T or R 40mg every morning for 6 consecutive days.Blood samples were taken at 4-6 days before oral administration in the morning,and according to the protocal,the blood samples were taken at 6d after oral administration.Serum concentrations of isosorbide mononitrate were measured with validated GC-ECD.The pharmacokinetic parameters and bioavailability of two isosorbide mononitrate sustained tablets were calculated and the bioequivalence was evaluated.RESULTS:The main pharmacokinetic parameters of tested and reference isosorbide mononitrate sustained tablet in volunteers administrated with an oral single dose of 40mg were as follows:T max(4.9±1.6)and(4.9±1.2)h,C max(719.42±183.72)and(726.52±177.55)ng·mL-1,t_ 1/2(3.9±0.6)and(3.7±0.9)h,AUC_ 0-t(5 687.38±1 271.64)and(5 586.05±1 290.01)ng·h·mL-1,AUC_ 0-∞(5 831.67± 1 308.47)and(5 719.20±1 329.54)ng·h·mL-1,and computed based on AUC_ 0-t,the relative bioavailability of tested isosorbide mononitrate sustained tablet was(103.0±17.1)%.The main pharmacokinetic parameters of tested and reference isosorbide mononitrate sustained tablet in volunteers administrated with oral multi-dose of 40 mg were as follows:T max-ss(4.9±1.4)and(4.9±1.5)h,C max-ss(745.43±143.83)and(747.55±130.72)ng·mL-1,AUC ss(7 860.24± 1 827.46)and(8 104.13±1 637.35)ng·h·mL-1,and the relative bioavailability of tested isosorbide mononitrate sustained tablet was(97.1±10.9)%.Tested with Wilcoxon(T max),ANOVA and two one-sided t test(AUC,C max),the main pharmacokinetic parameters of tested and reference isosorbide mononitrate sustained tablets showed no significant differences.The 90% confidential intervals of C max and AUC_ 0-t of tested formula were 93.26%～104.33% and 95.10%～108.83%,respectively.The 90% confidential intervals of C max-ss and AUC ss of tested formula were 93.97%～105.01% and 92.24%～101.08%,respectively.CONCLUSION:Two kinds of isosorbide mononitrate sustained tablets are bioequivalent.

Bioequivalence of Sotalol Tablets in Healthy Subjects by HPLC-FLU

Study on bioequivalence of cilostazol table in healthy volunteers

Studies on the Bioequivalence of Lorazepam Tablet in Healthy Volunteers

Studies on Bioequivalence of Ramipril Capsule in Healthy Volunteers

Bioequivalence of domestic and imported bisoproloi tablets

Bioequivalence of two kinds of amlodipine tablets in Chinese healthy volunteers

Bioequivalence of Levodopa Tablets in Healthy Volunteers

Bioequivalence of amlodipine besylate tablets in Chinese healthy volunteers

Study on bioequivalence of pravastatin sodium tablets in healthy volunteers

Bioequivalence of Isosorbide Mononitrate Sustained Tablets in Chinese Healthy Volunteers

Bioequivalence Study of Atenolol Tablets in Healthy Chinese Subjects Under Fasting and Fed Conditions

Study of the Bioequivalence of Gliclazide in Chinese Healthy Volunteers

[Pharmacokinetics and Relative Bioavailability of Ziprasidone Tablets in Chinese Healthy Volunteers].

Bioequivalent Study of Citalopram Tablets

A single-dose, randomized, crossover bioequivalence study of levamlodipine besilate tablets in healthy subjects

Bioequivalence of zopiclone tablet in Chinese healthy volunteers

Study on Bioequivalence of the Two Kinds of Isosorbide Mononotrate Tablets in Healthy Volunteers

A Study of the Bioequivalence of Fleroxacin Tablets in Healthy Chinese Volunteers

Relative bioavailability and bioequivalence of clopidogrel hydrogen sulfate tablets in healthy volunteers

Bioequivalence of Glipizide Controlled-Release Tablets in Chinese Healthy Volunteers

Pharmacokinetics and Bioequivalence of Domestic Nisoldipine Tablets in Healthy Volunteers